
Opinion|Videos|September 4, 2024
PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the NCCN Guidelines' recommendations for gallium-based versus non-gallium-based PET agents in prostate cancer imaging, and how does PSMA PET imaging impact prostate cancer care in your view?
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears Radiotherapy System with 20-Fold Increase in PET Imaging Sensitivity for Tumor Detection
2
FDA Clears 1.5T MRI Platform with Helium-Free Technology
3
Study: MRI May Help Predict Outcomes in Treatment for Triple-Negative Breast Cancer
4
Top Five Radiology Podcasts in 2025
5



























